CCJ

Unveiling Cameco – A Quick Stock Analysis

A strong performer from today's evening trading session is Cameco, whose shares rose 2.2% to $52.4 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

Cameco's Valuation Is in Line With Its Sector Averages:

Cameco Corporation provides uranium for the generation of electricity. The company belongs to the Basic Materials sector, which has an average price to earnings (P/E) ratio of 22.71 and an average price to book (P/B) ratio of 3.12. In contrast, Cameco has a trailing 12 month P/E ratio of 134.4 and a P/B ratio of 3.72.

Cameco's PEG ratio is 2.18, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Good EPS Growth and Similar Gross Margins to the Industry Average of 20.5%:

2018 2019 2020 2021 2022 2023
Revenue (M) $2,092 $1,863 $1,800 $1,475 $1,868 $2,588
Gross Margins 14% 13% 6% 0% 12% 22%
Net Margins 8% 4% -3% -7% 5% 14%
Net Income (M) $166 $74 -$53 -$103 $89 $361
Net Interest Expense (M) $72 $62 $66 $39 $39 $51
Depreciation & Amort. (M) $328 $276 $209 $190 $177 $220
Earnings Per Share $0.42 $0.19 -$0.13 -$0.26 $0.22 $0.83
EPS Growth n/a -54.76% -168.42% -100.0% 184.62% 277.27%
Avg. Price $10.33 $10.15 $9.82 $19.27 $24.15 $52.4
P/E Ratio 24.6 53.42 -75.54 -74.12 109.77 63.13
Free Cash Flow (M) $668 $527 $57 $458 $305 $688
Total Debt (M) $996 $997 $996 $996 $997 $1,284
Net Debt / EBITDA 0.71 -0.18 0.59 -4.63 -0.76 1.43
Current Ratio 2.38 6.51 6.4 5.18 5.92 1.55

Cameco has a strong EPS growth trend and generally positive cash flows. Additionally, the company's financial statements display a decent current ratio of 1.55 and healthy leverage levels. Furthermore, Cameco has similar gross margins to its peers.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS